{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"plin1-related-familial-partial-lipodystrophy","columns":[{"gene":"","key":"population-e825051eb7caf0931c29","label":"Lipodystrophy, familial partial, type 4","mondoId":"MONDO:0013478","onsetQualifier":null,"originColumnKey":"MONDO:0013478/OMIM:613877","originalViews":[{"key":"MONDO:0013478/OMIM:613877","label":"Lipodystrophy, familial partial, type 4","scopeLabel":"OMIM:613877","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["4d0cbf25a950b601ba830d328d66f44adc7359662ef126520e47b598a786f3bd","57b3da20a84cb433e026b11620ab9a199794eff9d975b43b2e05f9d11c6f5c45","6842e9bd35b54dafe0c73e03f0d4e9ecb8968d1401ba75e22a1926dca9cd8009","7b1a15c6f1c42719a14449ce56450b9fe4dc58e89ffe81b55effb308ee53edc5","a1473d22459fbf6303fde5a09b4b60a8bb3d132c9b301f412ed7def320fff309","b0d7f343530adc4f1d82df6d233a9c3920bb3d07f0007c2a0a376a74f2c83571","b7a80edaf643787064943d58a5ee28876b0b29a45c27e2518a03afdd28a2cc93","b9318f8c608505e084e5333a67ddbcdc1225a34e5a65fcf049f143b75bc73210","bffa8ff10d085709df5faba8fc6b7bd0670996d9f105fa33fdfca961bea00935","c552ea67929aabe69193709be2b51b6d8c4f2fc535ee71584af010d2036bc8b5","d32fafdcbaa3db8578b792aa9ac0f225505506c03768bc7f0eb16f9b00d445c9"],"recordQualifiers":{},"scopeLabel":"OMIM:613877","sourceIds":["OMIM:613877"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-53e5ad831066920ee798","label":"PLIN1-related familial partial lipodystrophy","mondoId":"MONDO:0013478","onsetQualifier":null,"originColumnKey":"MONDO:0013478/ORPHA:280356","originalViews":[{"key":"MONDO:0013478/ORPHA:280356","label":"PLIN1-related familial partial lipodystrophy","scopeLabel":"ORPHA:280356","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0a86732056b07b7f8a36bbb815f86adf8e1e531e0bc9cacf05eeded8344ef116","12476b88e5735d44fae92beafb19614b6226c4772fe2ad8da24987441d7a92f2","1258b0e50befd5c8943eb7a505bfa68556fa0c305ec5cbbf047db12e755cb129","1507bd8525bcbf70a5e203f1f9fb28346fb46dbcd180b9fd082e3f72582395f9","34b78e51721764acf1ec1823f88b36b367ee4605a1628059134858af3edc3909","6ea9b56e229297b42a3014968d607fdf2da416590a4e701b5439e5746275bf0c","6f639d0626fa2898eb0fe659afb087b417a0187073137215102840daa574f3fc","a4a8d828d54893d07789dd7095ced1f04cbfedf247f12634d7418c1af085ff85","aedc7bc00fc521058d9069022668d0ebdc1de93f2dc3752466eb856dec09dc01","c3195dd2395dbf0f18fd8f8bd3362619262094ebfe0fc1c8619f6a4ef9ea8d8c","c6fae851079c073300d967b6003096f63dab8a18038fd0427576a9353ab15917","c704965221ab494d24bda8586e48a129efb7a4f8f5e78240069054f3eb0b84b8","e039d1775a9801f51af3d743f98f34c62a2dd461734ff621f8a88b4cfcc5b1dc","e9a268ce75e476b1fa1b94b1118758678a43b25edec9502a5c8bb8717c159d75","e9b21b02b0ca12fe1f2c1a53af62501207f89718a7971394d268012ac6c16484","ee609c8771eccddb20728f3746718edd627021e8022bc4eb4c8f85dca166b699"],"recordQualifiers":{},"scopeLabel":"ORPHA:280356","sourceIds":["ORPHA:280356"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e825051eb7caf0931c29","population-53e5ad831066920ee798"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003117","HP:0000956","HP:0008981","HP:0001395","HP:0001397","HP:0000842","HP:0000822"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":27,"sourceGroups":{"orphanet":16,"published":11}},"features":[{"hpoId":"HP:0003117","label":"Abnormal circulating hormone concentration","primary":true},{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0008981","label":"Calf muscle hypertrophy","primary":true},{"hpoId":"HP:0001395","label":"Hepatic fibrosis","primary":true},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":true},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":true},{"hpoId":"HP:0000822","label":"Hypertension","primary":true},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0000789","label":"Infertility","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0000877","label":"Insulin-resistant diabetes mellitus at puberty","primary":false},{"hpoId":"HP:0100578","label":"Lipoatrophy","primary":false},{"hpoId":"HP:0009125","label":"Lipodystrophy","primary":false},{"hpoId":"HP:0009017","label":"Loss of gluteal subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0003635","label":"Loss of subcutaneous adipose tissue in limbs","primary":false},{"hpoId":"HP:0000876","label":"Oligomenorrhea","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false},{"hpoId":"HP:0003758","label":"Reduced subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0003712","label":"Skeletal muscle hypertrophy","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false}],"ledeHtml":"A rare genetic lipodystrophy characterized by loss of subcutaneous adipose tissue primarily affecting the lower limbs and gluteal region due to a defect in the PLIN1 gene. Associated features of insulin resistance, hepatic steatosis, dyslipidemia, hypertension, axillary acanthosis nigricans and muscular hypertrophy of the lower limbs are typical.","mondoId":"MONDO:0013478","node":{"canonicalSlug":"plin1-related-familial-partial-lipodystrophy","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"PLIN1-related familial partial lipodystrophy","originalSourceId":"ORPHA:280356","paragraphs":["A rare genetic lipodystrophy characterized by loss of subcutaneous adipose tissue primarily affecting the lower limbs and gluteal region due to a defect in the PLIN1 gene. Associated features of insulin resistance, hepatic steatosis, dyslipidemia, hypertension, axillary acanthosis nigricans and muscular hypertrophy of the lower limbs are typical."],"rawAttribution":"ORPHA:280356","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:40Z","upstream":"ORPHA:280356","url":"https://rarediseases.info.nih.gov/diseases/12601"},"ownColumnKeys":["population-e825051eb7caf0931c29","population-53e5ad831066920ee798"],"publication":"published","relationships":[{"kind":"parent","label":"familial partial lipodystrophy","mondoId":"MONDO:0020088","slug":"familial-partial-lipodystrophy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0a86732056b07b7f8a36bbb815f86adf8e1e531e0bc9cacf05eeded8344ef116","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003635","is_excluded":false,"label":"Loss of subcutaneous adipose tissue in limbs","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"12476b88e5735d44fae92beafb19614b6226c4772fe2ad8da24987441d7a92f2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009017","is_excluded":false,"label":"Loss of gluteal subcutaneous adipose tissue","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1258b0e50befd5c8943eb7a505bfa68556fa0c305ec5cbbf047db12e755cb129","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000789","is_excluded":false,"label":"Infertility","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1507bd8525bcbf70a5e203f1f9fb28346fb46dbcd180b9fd082e3f72582395f9","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000876","is_excluded":false,"label":"Oligomenorrhea","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"34b78e51721764acf1ec1823f88b36b367ee4605a1628059134858af3edc3909","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"4d0cbf25a950b601ba830d328d66f44adc7359662ef126520e47b598a786f3bd","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"57b3da20a84cb433e026b11620ab9a199794eff9d975b43b2e05f9d11c6f5c45","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0100578","is_excluded":false,"label":"Lipoatrophy","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6842e9bd35b54dafe0c73e03f0d4e9ecb8968d1401ba75e22a1926dca9cd8009","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"6ea9b56e229297b42a3014968d607fdf2da416590a4e701b5439e5746275bf0c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f639d0626fa2898eb0fe659afb087b417a0187073137215102840daa574f3fc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003758","is_excluded":false,"label":"Reduced subcutaneous adipose tissue","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"7b1a15c6f1c42719a14449ce56450b9fe4dc58e89ffe81b55effb308ee53edc5","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a1473d22459fbf6303fde5a09b4b60a8bb3d132c9b301f412ed7def320fff309","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a4a8d828d54893d07789dd7095ced1f04cbfedf247f12634d7418c1af085ff85","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001395","is_excluded":false,"label":"Hepatic fibrosis","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aedc7bc00fc521058d9069022668d0ebdc1de93f2dc3752466eb856dec09dc01","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b0d7f343530adc4f1d82df6d233a9c3920bb3d07f0007c2a0a376a74f2c83571","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b7a80edaf643787064943d58a5ee28876b0b29a45c27e2518a03afdd28a2cc93","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0003712","is_excluded":false,"label":"Skeletal muscle hypertrophy","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b9318f8c608505e084e5333a67ddbcdc1225a34e5a65fcf049f143b75bc73210","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bffa8ff10d085709df5faba8fc6b7bd0670996d9f105fa33fdfca961bea00935","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c3195dd2395dbf0f18fd8f8bd3362619262094ebfe0fc1c8619f6a4ef9ea8d8c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c552ea67929aabe69193709be2b51b6d8c4f2fc535ee71584af010d2036bc8b5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000876","is_excluded":false,"label":"Oligomenorrhea","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c6fae851079c073300d967b6003096f63dab8a18038fd0427576a9353ab15917","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c704965221ab494d24bda8586e48a129efb7a4f8f5e78240069054f3eb0b84b8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0100578","is_excluded":false,"label":"Lipoatrophy","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d32fafdcbaa3db8578b792aa9ac0f225505506c03768bc7f0eb16f9b00d445c9","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613877","disease_name":"Lipodystrophy, familial partial, type 4","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0009125","is_excluded":false,"label":"Lipodystrophy","onset_id":null,"reference":"PMID:21345103","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e039d1775a9801f51af3d743f98f34c62a2dd461734ff621f8a88b4cfcc5b1dc","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9a268ce75e476b1fa1b94b1118758678a43b25edec9502a5c8bb8717c159d75","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000877","is_excluded":false,"label":"Insulin-resistant diabetes mellitus at puberty","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9b21b02b0ca12fe1f2c1a53af62501207f89718a7971394d268012ac6c16484","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ee609c8771eccddb20728f3746718edd627021e8022bc4eb4c8f85dca166b699","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:280356","disease_name":"PLIN1-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003117","is_excluded":false,"label":"Abnormal circulating hormone concentration","onset_id":null,"reference":"ORPHA:280356","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12601\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:280356</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic lipodystrophy characterized by loss of subcutaneous adipose tissue primarily affecting the lower limbs and gluteal region due to a defect in the PLIN1 gene. Associated features of insulin resistance, hepatic steatosis, dyslipidemia, hypertension, axillary acanthosis nigricans and muscular hypertrophy of the lower limbs are typical.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12601\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"plin1-related-familial-partial-lipodystrophy","sourceDocuments":[{"name":"GARD: PLIN1-related familial partial lipodystrophy","reviewed":null,"source_release":"2026-10-25T03:41:40Z","url":"https://rarediseases.info.nih.gov/diseases/12601"}],"sourceNote":"","synonyms":["familial partial lipodystrophy associated with PLIN1 mutations","familial partial lipodystrophy type 4","FPLD due to PLIN1 mutations","FPLD4","lipodystrophy, familial partial, type 4","PLIN1-related FPLD"],"takeawayHtml":"","title":"PLIN1-related familial partial lipodystrophy"},"schemaVersion":1}
